Amplitudes of auditory evoked potentials (AEP) increase with the intensity/loudness of sounds (loudness-dependence of AEP, LDAEP), and the time between adjacent sounds (time-dependence of AEP, TDAEP). Both, blunted LDAEP and blunted TDAEP are markers of altered auditory function in schizophrenia (SZ). However, while blunted LDAEP has been attributed to altered serotonergic function, blunted TDAEP has been linked to altered NMDA receptor function. Despite phenomenological similarities of the two effects, no common pharmacological underpinnings have been identified. To test whether LDAEP and TDAEP are both affected by NMDA receptor blockade, two rhesus macaques passively listened to auditory clicks of 5 different intensities presented with stimulus-onset asynchronies ranging between 0.2 and 6.4 s. 8 AEP components were analyzed, including the N85, the presumed human N1 homolog. LDAEP and TDAEP were estimated as the slopes of AEP amplitude with intensity and the logarithm of stimulus-onset asynchrony, respectively. On different days, AEPs were collected after systemic injection of MK-801 or vehicle. Both TDAEP and LDAEP of the N85 were blunted by the NMDA blocker MK-801 and recapitulate the SZ phenotype. In summary, LDAEP and TDAEP share important pharmacological commonalities that may help identify a common pharmacological intervention to normalize both electrophysiological phenotypes in SZ.
Introduction
Individuals with schizophrenia (SZ) exhibit auditory deficits (Javitt and Sweet, 2015; Leitman et al., 2010 ) that manifest, for example, as impaired performance in delayed pitch-discrimination tasks (Javitt et al., 1997; March et al., 1999; Rabinowicz et al., 2000; Strous et al., 1995) , or impaired extraction of prosody from speech (Kantrowitz et al., 2013) . These behavioral deficits go along with altered auditory evoked potentials in several passive listening tasks. Relative to healthy controls, SZ exhibit a reduced dynamic range of N1-P2 amplitude in response to sounds of different intensity (loudness-dependence of auditory evoked potential, LDAEP) (Gudlowski et al., 2009; Juckel et al., 2003 Juckel et al., , 2008a Park et al., 2010) . Similarly, SZ exhibit a reduced dynamic range of P1 and N1 amplitude in response to sounds preceded by different amounts of silence (time-dependence of auditory evoked potentials, TDAEP) (Erwin et al., 1991 (Erwin et al., , 1994 Roth et al., 1991 Roth et al., , 1980 Shelley et al., 1999) .
Both LDAEP and TDAEP are most evident for the N1 component, and may thus reflect activity of the same neural generators. Both are blunted in SZ, and in both cases, this blunting is caused by reduction of peak amplitudes that are observed for the loudest tones and for tones preceded by longest periods of silence. These similarities support the notion of a common underlying pathology. In particular, they are both consistent with the hypothesis that structural and molecular alterations in the disease prevent the generation of maximal post-synaptic currents/potentials in pyramidal cells of auditory cortex (Javitt et al., 1996; Lewis and Sweet, 2009) .
Work in monkeys and humans has shown that non-competitive NMDA receptor antagonists such as ketamine or PCP mimic blunted TDAEP observed in SZ (Boeijinga et al., 2007; Javitt et al., 2000) . However, to date it is not known if NMDA receptor blockade also mimics blunted LDAEP as would be expected if both phenotypes reflect the same pathology, and if this pathology is accurately modeled by NMDA receptor blockade. This question is particularly relevant since other work has implicated altered serotonergic neuro-transmission as the reason for blunted LDAEP in SZ (Gudlowski et al., 2009; Juckel et al., 2008a Juckel et al., , 2003 Park et al., 2010) .
To answer this question we developed an auditory paradigm to simultaneously measure LDAEP and TDAEP in the non-human primate, and tested if both are affected by MK-801, a highly selective non-competitive NMDA antagonist. The results show that both, LDAEP and TDAEP, are blunted by MK-801. This finding supports the notion that both phenotypes are caused by a common pathological mechanism that can be mimicked in the non-human primate by NMDA receptor blockade.
Materials and methods

Subjects
Experiments were performed on 2 adult male macaque monkeys (Macaca mulatta, animals S and W). The treatment of the monkeys was in accordance with the guidelines set by the U.S. Department of Health and Human Services (National Institutes of Health) for the care and use of laboratory animals. All methods were approved by the Institutional Animal Care and Use Committee at the University of Pittsburgh. All animals have previously been exposed to similar passive listening paradigms in previous studies (Teichert, 2016; Teichert et al., 2016) .
Cranial EEG recordings
The rhesus EEG recording system was designed to be as similar as possible to human scalp recordings, while reducing setup times and enabling long-term recordings over the period of many months. Details of the EEG recording system were reported previously (Teichert, 2016; Teichert et al., 2016) . Briefly, animals had 33 electrodes implanted into 1 mm deep holes in the cranium covering roughly the same anatomy as the international 10-20 system (Teichert, 2016).
Experimental Setup
Experiments were performed in a small (4′ wide by 4′ deep by 8′ high) sound-attenuating and electrically insulated recording booth (Eckel Noise Control Technology). Animals were positioned and headfixed in custom-made primate chairs (Scientific Design). Cranial EEG potentials were recorded with a 32-channel digital amplifier system (RHD2000, Intan). Experimental control was handled by a windows PC running an in-house modified version of the Matlab software-package monkeylogic and presented by routines of the Matlab package Psychtoolbox. Sounds were presented using a single element 4 in. fullrange driver (Tang Band W4-1879) located 8 in. in front of the animals.
Stimuli and experimental design
The auditory paradigm was a modification of a paradigm we used previously (Teichert, 2016; Teichert et al., 2016) . In this variant of the paradigm, animals passively listened to 0.1 ms long bi-phasic clicks of 5 different intensities (62, 68, 74, 80, 86 dB SPL) (Fig. 1) . Times between individual clicks (stimulus-onset asynchrony, SOA) were drawn from an exponential distribution truncated at 12.8 s and a constant offset of 250 ms. Click intensity and SOA remained constant 90% percent of the time leading to sequences of clicks with identical intensity and timing.
Click presentations were structured into blocks between 9 and 12 min duration. Each recording session consisted of 12 blocks. After block number four, the subjects were given a 0.4 mL intramuscular injection of either MK-801 (0.1 mg/kg) or vehicle. The same injection was repeated after block number 8 to maintain an approximately constant concentration of MK-801. The control and experimental condition occurred on alternating days, with the experimental condition never occurring more than once a week.
Auditory evoked potentials
Raw data was down-sampled from 5000 to 500 Hz and filtered with a 70 Hz low-pass filter. The filtered data was cut into short epochs around the onset of each sound (−150-750 ms). A subtraction method was used to reduce AEP superposition for tones with short SOAs (Teichert et al., 2016) . The data was then exported for use with the statistics software R (R Development Core Team, 2009). Trials with peak-to-peak amplitudes above 1500 µV were excluded to minimize motion artifacts. The remaining trials were sorted into bins of SOA with a width of 1 octave (0.2-0.4 s, 0.4-0.8 s, etc) and averaged.
Quantifying LDAEP and TDAEP
Previous work in the same animals identified 8 distinct middle and long-latency components (Teichert, 2016) . Most components could readily be identified in all animals despite inter-individual differences in timing and topography. For each animal, each component was associated with a time-window and a list of channels. Component amplitudes on each trial were estimated by averaging activity across the corresponding channels and time-bins.
For each recording session, a simple linear model was used to quantify LDAEP and TDAEP.
Here L refers to the intensity of the clicks measured in dB SPL, and T refers to the time between tones, i.e., SOA, measured on a log 2 -scale. λ is the estimate of LDAEP, and τ is the estimate of TDAEP.
For each animal and AEP component, a linear model was used to determine whether λ and τ are significantly different from zero on days with vehicle injection. Rejection of the corresponding null-hypothesis indicated that a particular component was significantly modulated by intensity, SOA or both. A similar approach was used to test if the MK-801 significantly altered the relationship between intensity or SOA and AEP amplitude. To account for potential gradual changes of λ or τ over the course of successive recording sessions, we included session number as an additional predictor. Effect of drug and session number on λ and τ was tested using type-II sums-of-squares to account for the fact that session number and drug condition were not balanced.
Results
High-density tone-evoked cranial EEG responses were measured in 
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